Invesco’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.24M | Buy |
470,333
+384,566
| +448% | +$2.65M | ﹤0.01% | 2387 |
|
2025
Q1 | $247K | Buy |
85,767
+55,791
| +186% | +$161K | ﹤0.01% | 3413 |
|
2024
Q4 | $141K | Sell |
29,976
-686
| -2% | -$3.22K | ﹤0.01% | 3564 |
|
2024
Q3 | $109K | Sell |
30,662
-381
| -1% | -$1.36K | ﹤0.01% | 3590 |
|
2024
Q2 | $192K | Sell |
31,043
-465,636
| -94% | -$2.89M | ﹤0.01% | 3617 |
|
2024
Q1 | $4.69M | Buy |
496,679
+20,473
| +4% | +$193K | ﹤0.01% | 2276 |
|
2023
Q4 | $3.21M | Buy |
+476,206
| New | +$3.21M | ﹤0.01% | 2438 |
|
2023
Q2 | – | Sell |
-12,469
| Closed | -$35.5K | – | 3867 |
|
2023
Q1 | $35.5K | Sell |
12,469
-509
| -4% | -$1.45K | ﹤0.01% | 3757 |
|
2022
Q4 | $94.5K | Buy |
12,978
+1,737
| +15% | +$12.6K | ﹤0.01% | 3814 |
|
2022
Q3 | $90K | Buy |
11,241
+141
| +1% | +$1.13K | ﹤0.01% | 3827 |
|
2022
Q2 | $55K | Sell |
11,100
-212,360
| -95% | -$1.05M | ﹤0.01% | 3930 |
|
2022
Q1 | $5.28M | Buy |
223,460
+115,993
| +108% | +$2.74M | ﹤0.01% | 2339 |
|
2021
Q4 | $1.9M | Sell |
107,467
-488,590
| -82% | -$8.64M | ﹤0.01% | 2797 |
|
2021
Q3 | $16.8M | Buy |
+596,057
| New | +$16.8M | ﹤0.01% | 1673 |
|